Trials / Completed
CompletedNCT07348562
Omega-3, Inflammation in ADHD With AI
Omega-3 Fatty Acids, Inflammation and Attention Deficit Hyperactivity Disorder (ADHD) With AI (OmInADHDAI)- A Double-blind Randomized Controlled Trial of High Dose Omega-3 Fatty Acids in Children With ADHD With High Inflammation Status
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- China Medical University Hospital · Academic / Other
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in children with attention deficit hyperactivity disorder (ADHD).
Detailed description
This is a 12 week study to investigate the effects of omega-3 PUFAs in children (6-12 years-old) with ADHD. The primary outcome will be the clinical symptoms The secondary outcomes will be inflammatory biomarkers, cognitive function and physiological markers such as heart-rate variability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omega-3 | Omega-3 PUFAs |
| DIETARY_SUPPLEMENT | Placebo | Olive oil |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2021-09-04
- Completion
- 2021-11-20
- First posted
- 2026-01-16
- Last updated
- 2026-01-16
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT07348562. Inclusion in this directory is not an endorsement.